<?xml version="1.0" encoding="UTF-8"?>
<ref id="B332-vaccines-08-00036">
 <label>332.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Jangalwe</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Shultz</surname>
    <given-names>L.D.</given-names>
   </name>
   <name>
    <surname>Mathew</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Brehm</surname>
    <given-names>M.A.</given-names>
   </name>
  </person-group>
  <article-title>Improved B cell development in humanized NOD-scid IL2Rgamma(null) mice transgenically expressing human stem cell factor, granulocyte-macrophage colony-stimulating factor and interleukin-3</article-title>
  <source>Immun. Inflamm. Dis.</source>
  <year>2016</year>
  <volume>4</volume>
  <fpage>427</fpage>
  <lpage>440</lpage>
  <pub-id pub-id-type="doi">10.1002/iid3.124</pub-id>
  <pub-id pub-id-type="pmid">27980777</pub-id>
 </element-citation>
</ref>
